REMSleep Navigates Founder's Passing, Appoints New CEO for DeltaWave Launch

REMSleep Holdings Inc. (OTCQB: RMSL), a medical device company dedicated to sleep apnea treatment, has announced a significant leadership transition following the passing of its visionary founder, Thomas Wood. Wood, who founded the company and served as Chairman and CEO, passed away on February 26, 2026. He was a prolific inventor, securing his first U.S. patent for a Nasal Air interface in 1981 and amassing 26 patents for CPAP interface components. His lifelong mission to improve patient care culminated in the development of the company's flagship product, the DeltaWave Nasal Pillow System. Under his leadership, REMSleep achieved critical milestones including FDA 510(k) clearance, PDAC coding approval for Medicare reimbursement, and the buildout of manufacturing and distribution infrastructure, positioning the company for commercial launch.

In a planned succession, the Board of Directors has been reconstituted to ensure continuity. Anita Michaels, Thomas Wood's sister, the company's COO, and now majority shareholder, has been elected Chairman of the Board. She brings decades of shared history and a deep understanding of the company's mission from collaborating with her brother since 1981. Jeffrey Marshall has been appointed as the new Chief Executive Officer and Director, bringing extensive industry experience in sales, marketing, and commercial strategy to lead the company's next growth phase. Alexander Johnson has also been appointed as a Director, adding expertise in corporate restructuring and capital markets. This transition, which was in process prior to Wood's passing, is designed to execute the commercial opportunity he created.

The core message is one of resilience and forward momentum. The DeltaWave Nasal Pillow System is now commercially available, representing the first product in a planned broader portfolio. Management emphasizes a strong foundation for growth, with immediate priorities focused on driving sales, building brand awareness, and establishing partnerships with Durable Medical Equipment providers and sleep specialists. The strategic roadmap extends beyond sleep apnea, aiming to apply Wood's engineering principles to other chronic respiratory and neurological diseases. The company's commitment, as echoed by both Michaels and Marshall, is to honor Thomas Wood's legacy by delivering the DeltaWave technology to patients and developing the future pipeline he envisioned. For more information, visit the official www.remsleep.com website, a key resource for stakeholders.